Table 2. Median percentage reduction in seizure frequency.^* .

Trial	Placebo		Lacosamide 200 mg/day		Lacosamide 400 mg/day		Lacosamide 600 mg/day
	N	%	N	%	N	%	N	%
Ben-Menachem et al. (2007)	96	10%	107	26%	107	39%	105	40%
Chung et al. (2010b)	104	20.8%	–	–	201	37.3%	97	37.8%
Halász et al. (2009)	159	20.5%	160	35.3%	158	36.4%	–	–

Notes.

^*Compares maintenance phase to baseline period.